Volume 12, Issue 2 (Pajouhan Scientific Journal, Winter 2014)                   Pajouhan Sci J 2014, 12(2): 1-7 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khalilian A, Karampourian A, Tavakoli M. Determination of effectiveness of four-drug regime in eradication of Helicobacter Pylori (H.Pylori) infection in patients of Hamadan. Pajouhan Sci J 2014; 12 (2) :1-7
URL: http://psj.umsha.ac.ir/article-1-33-en.html
1- , Karampor1@yahoo.com
Abstract:   (7466 Views)
Background and objectives: Four-drugs treatment included of Bismuth–Omperazole–Metronidazole and Amoxicillin have been used as first line treatment for Helicobacter Pylori eradication by many of physician in Iran. However, there is an uncertainty for effectiveness of the regime on patients of Hamadan with the resistance rate of this regime reported in different parts of the country. Present study attempt to evaluate the effectiveness of this regime as first line treatment of H. Pylori in patients of Hamadan..
Method: There are 100 patients with recognized H.pylori infection who could terminate this study. At first, these patients treated by four-drugs regime for 2 weeks, then they treated with Omprazole for 1 month. Successful eradication was determined as negative Urease Test with Carbon 13.
Results: The average of individual ages was 38±11.78 years old. 57% of patients were men. The eradication rate of H.pylori was 80% and the eradication had no significant correlation with the age, gender, clinical symptoms and endoscopic findings.
 Conclusion: Four-drugs treatment included of Omperazole-Metronidazole-Amoxicillin and Bismuth is effective in patients of Hamadan and still could be applicable in H.pylori treatment as the first line treatment
Full-Text [PDF 139 kb]   (2119 Downloads)    
Type of Study: Research Article |
Received: 2014/09/10 | Accepted: 2014/09/10 | Published: 2014/09/10

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Pajouhan Scientific Journal

Designed & Developed by : Yektaweb